abstract |
The present invention relates to new 2,3-cyclically fused 1,4-dihydropyridines of the general formula (I), in which R, R¹, R², D and E have the meaning given in the description, processes for their preparation and their use as medicaments, preferably for the treatment of the central nervous system. |